Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Wuwei Fuzheng Yijing Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by The First Affiliated Hospital of He'nan University of Chinese Medicine for the treatment of male infertility. The decoction is formulated based on TCM principles to "strengthen the body's resistance" (Fuzheng) and "benefit the essence" (Yijing), targeting improvements in semen quality and sperm DNA integrity. Clinical research, including a randomized controlled trial (ChiCTR2200063340), has investigated its efficacy in improving sperm quality parameters and reducing the sperm DNA fragmentation index (DFI). A unique focus of recent study involves evaluating the decoction's potential to mitigate the presence and impact of environmental microplastics in human semen, comparing its performance against standard antioxidant treatments like Vitamin E and Coenzyme Q10.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Wuwei Fuzheng Yijing Decoction.